| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 129, 177-182, Copyright © 1987 by American Society for Investigative Pathology
REGULAR ARTICLES |
N Nartey, MG Cherian and D Banerjee
Department of Pathology, University of Western Ontario Health Sciences Center, London, Canada.
High levels of metallothionein (MT) are present in the developing mammalian liver; however, a remarkable decrease is observed during postnatal life after weaning. This developmental profile is similar to that of certain oncofetal gene products such as alpha-fetoprotein, which is used as a tumor marker. This study deals with the reexpression of MT genes in thyroid tumors. With an immunohistochemical method, the presence of MT was investigated in tissue sections of normal and neoplastic human thyroid glands. Tissue sections of 34 thyroid tumors and 10 normal human thyroid glands were studied by means of the peroxidase-antiperoxidase method. MT was localized in 31 of the thyroid gland tumors. MT was also present in two of the normal thyroid glands. These findings indicate that although high levels of MT are mainly found in the fetal liver, it may also be expressed actively in certain human thyroid neoplastic tissues, and occasionally in normal thyroid tissue.
This article has been cited by other articles:
![]() |
B.-H. Bay, R. Jin, J. Huang, and P.-H. Tan Metallothionein as a prognostic biomarker in breast cancer. Experimental Biology and Medicine, October 1, 2006; 231(9): 1516 - 1521. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-G. Liu, L. Zhang, Y. Jiang, D. Chatterjee, C. M. Croce, K. Huebner, and L. Y.Y. Fong Modulation of Gene Expression in Precancerous Rat Esophagus by Dietary Zinc Deficit and Replenishment Cancer Res., September 1, 2005; 65(17): 7790 - 7799. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-K. Tai, O. J.-K. Tan, V. T.-K. Chow, R. Jin, J. L. Jones, P.-H. Tan, A. Jayasurya, and B.-H. Bay Differential Expression of Metallothionein 1 and 2 Isoforms in Breast Cancer Lines with Different Invasive Potential: Identification of a Novel Nonsilent Metallothionein-1H Mutant Variant Am. J. Pathol., November 1, 2003; 163(5): 2009 - 2019. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hecht, D. Jung, V. V. Prabhu, P. J. Munson, M. P. Hoffman, and H. K. Kleinman Metallothionein Promotes Laminin-1-induced Acinar Differentiation in Vitro and Reduces Tumor Growth in Vivo Cancer Res., September 15, 2002; 62(18): 5370 - 5374. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. A. Ebert, T. Günther, J. Hoffmann, J. Yu, S. Miehlke, H. U. Schulz, A. Roessner, M. Korc, and P. Malfertheiner Expression of Metallothionein II in Intestinal Metaplasia, Dysplasia, and Gastric Cancer Cancer Res., April 1, 2000; 60(7): 1995 - 2001. [Abstract] [Full Text] |
||||
![]() |
M. P. Waalkes, S. Rehm, and M. G. Cherian Repeated Cadmium Exposures Enhance the Malignant Progression of Ensuing Tumors in Rats Toxicol. Sci., March 1, 2000; 54(1): 110 - 120. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |